Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologicsAlan Menter, Craig A. Elmets, Arthur Kavanaugh et al.|Journal of the American Academy of Dermatology|2019Cited by 917
PsoriasisJacqueline Greb, Alice B. Gottlieb, Ari M. Goldminz et al.|Nature Reviews Disease Primers|2016Cited by 893
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adultsAmy S. Paller, Adelaide A. Hebert, Wynnis L. Tom et al.|Journal of the American Academy of Dermatology|2016Cited by 564
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbiditiesCraig A. Elmets, Alan Menter, Craig L. Leonardi et al.|Journal of the American Academy of Dermatology|2019Cited by 484
Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trialEmma Guttman‐Yassky, Mark Lebwohl|Journal of the American Academy of Dermatology|2018Cited by 334